EricBartonSuhlerMDMPH
Ophthalmology • Portland, ORRetinal Disease, Uveitis
Professor, Ophthalmology and Public Health, Oregon Health and Science University, and Chief of Ophthalmology, VA Portland Health Care System
Dr. Suhler is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3375 Sw Terwilliger Blvd
Portland, OR 97239Phone+1 503-494-5023Fax+1 503-494-6875
Education & Training
Oregon Health & Science UniversityMPH, Epidemiology and Biostatistics, Outstanding Thesis, 1999 - 2007
Oregon Health & Science University (OHSU Health)Residency, Ophthalmology, 1996 - 2000
University of HawaiiInternship, Internal Medicine, 1995 - 1996
University of Texas Southwestern Medical SchoolClass of 1995
Certifications & Licensure
OR State Medical License 2002 - 2025
MD State Medical License 2000 - 2003
HI State Medical License 1995 - 1996
American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
- Fellow (FAAO) American Academy of Ophthalmology
Clinical Trials
- A Clinical Trial of Infliximab for Uveitis Start of enrollment: 2001 Aug 01
- Rituximab in the Treatment of Scleritis and Non-Infectious Orbital Inflammation Start of enrollment: 2007 Jan 01
- Adalimumab (Humira) in the Treatment of Refractory Non-infectious Uveitis Start of enrollment: 2008 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- Electroretinography of disease activity and treatment response in birdshot chorioretinopathy.Christopher R Rosenberg, Elizabeth White, Aseel Alsamarraie, Sandip Suresh, Wayne Tschetter
Eye. 2025-03-28 - SUCCESSFUL TREATMENT OF CANCER-ASSOCIATED RETINOPATHY WITH INTRAVITREAL DEXAMETHASONE IMPLANT FOLLOWED BY A 0.18-MG FLUOCINOLONE IMPLANT WITHOUT SYSTEMIC IMMUNOSUPPRES...Lingling Huang, Paul Yang, Christina Flaxel, Eric Suhler, Phoebe Lin
Retinal Cases & Brief Reports. 2025-03-01 - Incidence and Outcome of Cataract in Eyes with Scleritis and Episcleritis.Michelle J Sun, Bernard A Rosner, Craig W Newcomb, Kurt A Dreger, Pichaporn Artornsombudh
Ocular Immunology and Inflammation. 2025-02-12
Press Mentions
NEW PRODUCT APPLICATIONS: Yutiq Implant for Chronic Noninfectious Posterior-Segment UveitisApril 1st, 2019
Professional Memberships
- Fellow
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
